225 related articles for article (PubMed ID: 31227873)
21. [Prognostic analysis of 525 Chinese patients with diffuse large B cell lymphoma].
Fu ZY; Zhu J; Song YQ; Liu WP; Ji XQ; Zhan SY
Beijing Da Xue Xue Bao Yi Xue Ban; 2014 Jun; 46(3):405-11. PubMed ID: 24943019
[TBL] [Abstract][Full Text] [Related]
22. Benefit of consolidative radiation therapy for primary bone diffuse large B-cell lymphoma.
Tao R; Allen PK; Rodriguez A; Shihadeh F; Pinnix CC; Arzu I; Reed VK; Oki Y; Westin JR; Fayad LE; Medeiros LJ; Dabaja B
Int J Radiat Oncol Biol Phys; 2015 May; 92(1):122-9. PubMed ID: 25754633
[TBL] [Abstract][Full Text] [Related]
23. Role of radiation therapy in primary tonsil large B cell lymphoma: a SEER-based analysis.
Jia J; Chen W
Radiat Oncol; 2021 Oct; 16(1):193. PubMed ID: 34600539
[TBL] [Abstract][Full Text] [Related]
24. [Clinical characteristics, cell origin and prognosis of primary gastrointestinal diffuse large B-cell lymphoma: a report of 40 cases].
Yang YL; Wang J; Zhao LZ; Gao ZF; Jing HM; Ke XY
Ai Zheng; 2008 Jun; 27(6):636-41. PubMed ID: 18570740
[TBL] [Abstract][Full Text] [Related]
25. Trends in Survival of Patients with Primary Gastric Diffuse Large B-Cell Lymphoma: An Analysis of 7051 Cases in the SEER Database.
Liu PP; Xia Y; Bi XW; Wang Y; Sun P; Yang H; Li ZM; Jiang WQ
Dis Markers; 2018; 2018():7473935. PubMed ID: 30410635
[TBL] [Abstract][Full Text] [Related]
26. Parotid gland lymphoma: prognostic analysis of 2140 patients.
Feinstein AJ; Ciarleglio MM; Cong X; Otremba MD; Judson BL
Laryngoscope; 2013 May; 123(5):1199-203. PubMed ID: 23576299
[TBL] [Abstract][Full Text] [Related]
27. Surgery shows survival benefit in patients with primary intestinal diffuse large B-cell lymphoma: A population-based study.
Wang M; Ma S; Shi W; Zhang Y; Luo S; Hu Y
Cancer Med; 2021 May; 10(10):3474-3485. PubMed ID: 33931950
[TBL] [Abstract][Full Text] [Related]
28. Prognostic factors for primary diff use large B-cell lymphoma of the brain.
Zhou Z; Chen J
Asian J Surg; 2023 Oct; 46(10):4357-4362. PubMed ID: 36535876
[TBL] [Abstract][Full Text] [Related]
29. A retrospective analysis of primary gastric diffuse large B-cell lymphoma with or without concomitant mucosa-associated lymphoid tissue (MALT) lymphoma components.
Li X; Xia B; Guo S; Zhan Z; Zhang L; Zhao D; Wu X; Zhang Y
Ann Hematol; 2013 Jun; 92(6):807-15. PubMed ID: 23417758
[TBL] [Abstract][Full Text] [Related]
30. Survival Analysis of Patients with Osseous Malignant Vascular Tumors: Results of the Surveillance, Epidemiology, and End Results (SEER) Database from 1973 to 2015.
Wang W; Hong J; Meng J; Wu H; Shi M; Yan S; Huang Y
Med Sci Monit; 2019 Jul; 25():5525-5535. PubMed ID: 31344019
[TBL] [Abstract][Full Text] [Related]
31. Primary diffuse large B-cell lymphoma of orbit: A population-based analysis.
Chen YQ; Yue ZF; Chen SN; Tong F; Yang WH; Wei RL
Front Med (Lausanne); 2022; 9():990538. PubMed ID: 36186798
[TBL] [Abstract][Full Text] [Related]
32. Role of local treatment in primary breast B-cell non-Hodgkin's lymphoma: a propensity score matching-based analysis from SEER database.
Zhang M; Liu N; Wang BY; Zhang J; Zhao A; Yang J; Yang J
Eur Rev Med Pharmacol Sci; 2022 Jan; 26(1):22-31. PubMed ID: 35049015
[TBL] [Abstract][Full Text] [Related]
33. [Comparison of Different Staging Systems and Prognostic Analysis in 68 Cases of Primary Intestinal Diffuse Large B Cell Lymphoma].
Wang X; Wang CY; Xu W; Yang HL; Zhao HF; Wang XF; Wang YF; Yu Y; Zhang YZ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Feb; 27(1):52-60. PubMed ID: 30738447
[TBL] [Abstract][Full Text] [Related]
34. Presence of multiple abnormal immunologic markers is an independent prognostic factor of diffuse large B-cell lymphoma.
Cao Y; Liu Z; Wu W; Qian Y; Shi Q; Shen R; Ouyang B; Xu P; Cheng S; Ye J; Lu Y; Wang C; Yang C; Wang L; Zhao W
Front Med; 2019 Feb; 13(1):94-103. PubMed ID: 30706260
[TBL] [Abstract][Full Text] [Related]
35. [Expression of dendritic cell marker CD21 is a positive prognostic factor in diffuse large B-cell lymphoma].
Yao WK; Wang YP; Peng F; Zheng Y; Zou YB; Gao JN; Liu XL
Zhonghua Bing Li Xue Za Zhi; 2012 Dec; 41(12):818-22. PubMed ID: 23324230
[TBL] [Abstract][Full Text] [Related]
36. Primary testicular diffuse large B-cell lymphoma: a population-based study on the incidence, natural history, and survival comparison with primary nodal counterpart before and after the introduction of rituximab.
Gundrum JD; Mathiason MA; Moore DB; Go RS
J Clin Oncol; 2009 Nov; 27(31):5227-32. PubMed ID: 19770371
[TBL] [Abstract][Full Text] [Related]
37. Serum albumin level at diagnosis of diffuse large B-cell lymphoma: an important simple prognostic factor.
Bairey O; Shacham-Abulafia A; Shpilberg O; Gurion R
Hematol Oncol; 2016 Dec; 34(4):184-192. PubMed ID: 26052918
[TBL] [Abstract][Full Text] [Related]
38. Nomograms Predict Survival Outcome of Primary Intramedullary Spinal Cord Lymphoma Patients.
Wu Q; Yang Z; Xu Y
Med Sci Monit; 2019 Oct; 25():7418-7429. PubMed ID: 31579048
[TBL] [Abstract][Full Text] [Related]
39. Coexpression of MYC and BCL-2 predicts prognosis in primary gastrointestinal diffuse large B-cell lymphoma.
Xia B; Zhang L; Guo SQ; Li XW; Qu FL; Zhao HF; Zhang LY; Sun BC; You J; Zhang YZ
World J Gastroenterol; 2015 Feb; 21(8):2433-42. PubMed ID: 25741152
[TBL] [Abstract][Full Text] [Related]
40. Diffuse large B-cell lymphoma of the ocular adnexal region: a nation-based study.
Rasmussen PK; Ralfkiaer E; Prause JU; Sjö LD; Toft PB; Siersma VD; Heegaard S
Acta Ophthalmol; 2013 Mar; 91(2):163-9. PubMed ID: 22551232
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
